Drug Discovery Seminars
9:00 AM to 10:00 AM | July 14, 2017

Patent strategy: Therapeutics, clinical diagnostics and research tools

William K. Merkel, Ph.D., J.D.
Marshall, Gerstein and Borun, LLP
Lynn L. Janulis, Ph.D., J.D.
Lynn L. Janulis, Ph.D., J.D.
Drug Discovery Seminars
11:00 AM to 12:00 PM | July 7, 2017

Therapeutic approaches to KRAS

Frank McCormick, Ph.D.
University of California, San Francisco
Drug Discovery Seminars
9:00 AM to 10:00 AM | May 12, 2017

Chemotherapy for the 21st century: Non-ototoxic designer aminoglycosides

Jochen Schacht, Ph.D.,
U-M Medical School
Drug Discovery Seminars
9:00 AM to 10:00 AM | May 10, 2017

Innovative academic drug discovery

Philip S. Low, Ph.D.
Purdue University
Drug Discovery Seminars
9:00 AM to 10:00 AM | May 5, 2017

Drug discovery targeting epigenetics – From cancer therapeutics to “female Viagra”

Duxin Sun, Ph.D.
U-M College of Pharmacy
Drug Discovery Seminars
9:00 AM to 10:00 AM | April 28, 2017

Next-generation dihydrofolate reductase inhibitors for the treatment of neglected parasitic infections

Stephen Thomas, Ph.D.
Turing Pharmaceuticals
Drug Discovery Seminars
9:00 AM to 10:00 AM | April 7, 2017

Chemical probing of translational control in cancer

Amanda Garner, Ph.D.
U-M College of Pharmacy
Drug Discovery Seminars
9:00 AM to 10:00 AM | March 24, 2017

A Novel Pan-ALDH1A Inhibitor Induces Necroptosis in Ovarian Cancer Stem-Like cells and Synergizes with Chemotherapy to Improve Outcomes

Ronald Buckanovich, M.D., Ph.D.
Women's Cancer Research Center, University of Pittsburgh
Drug Discovery Seminars
9:00 AM to 10:00 AM | November 17, 2016

For Scientists By Scientists: Case Studies in Eli Lilly’s Open Innovation Drug Discovery Platform

Julia Marie Clay, Ph.D.
Eli Lilly and Company
Drug Discovery Seminars
9:00 AM to 10:00 AM | November 7, 2016

Discovery of selective Orexin-2 antagonists for the treatment of Primary Insomnia

Nicholas Carruthers, Ph.D.
Janssen
Drug Discovery Seminars
9:00 AM to 10:00 AM | October 28, 2016

Fishing, drug development and the prevention of acquired hearing loss

Ed Rubel, Ph.D.
University of Washington
Drug Discovery Seminars
9:00 AM to 10:00 AM | October 13, 2016

The Yale PITCH Biotech Accelerator: Building on individual successes to Systema2ze success for others

Craig Crews, Ph.D.
Yale University
Drug Discovery Seminars
9:00 AM to 10:00 AM | September 9, 2016

Antibiotic discovery for tuberculosis: Returning to a “golden target”, RNA polymerase

George Garcia, Ph.D.
U-M College of Pharmacy
Drug Discovery Seminars
9:00 AM | August 29, 2016

Medicinal chemistry education: Issues and opportunities

Michael F. Rafferty, Ph.D.
University of Kansas
Drug Discovery Seminars
9:00 AM to 10:00 AM | May 20, 2016

A novel family of natural products that targets uropathogenic Escherischia coli iron acquisition

Laura Mike, Ph.D.
U-M Medical School
Drug Discovery Seminars
9:00 AM to 10:00 AM | May 13, 2016

Treating zika virus infection by targeting ER-associated quality control pathway

Billy Tsai, Ph.D.
University of Michigan
Drug Discovery Seminars
9:00 AM to 10:00 AM | May 6, 2016

Early clinical research takes patients

J. Frederick Pritchard, Ph.D.
Celerion
Drug Discovery Seminars
9:00 AM to 10:00 AM | January 22, 2016

Designer niches for analyzing cancer: From initiation to metastasis

Lonnie Shea, Ph.D.
U-M College of Engineering
Drug Discovery Seminars
9:00 AM to 10:00 AM | January 15, 2016

Molecular target identification in kidney disease across disciplines and continents

Matthias Kretzler, M.D.
U-M Medical School